Calcitonin Gene-Related Peptide Receptor Antagonists

Pharmacologic agents that block NOCICEPTIVE PAIN signaling from CALCITONIN GENE-RELATED PEPTIDE RECEPTORS. They may be useful for the treatment of pain associated with MIGRAINE DISORDERS and OSTEOARTHRITIS.

Also Known As:

CGRP Receptor Antagonists; GEPANTS; Antagonist, CGRP Receptor; Antagonists, CGRP Receptor; CGRP R Inhibitor; CGRP R Inhibitors; Calcitonin Gene Related Peptide Receptor Antagonist; Calcitonin Gene Related Peptide Receptor Antagonists; Inhibitor, CGRP-R; Inhibitors, CGRP-R; Receptor Antagonist, CGRP; Receptor Antagonists, CGRP; CGRP Receptor Antagonist; CGRP-R Inhibitor; CGRP-R Inhibitors; Calcitonin Gene-Related Peptide Receptor Antagonist; GEPANT

Chemical Actions and Uses
- Pharmacologic Actions: 164
  - Therapeutic Uses: 49043
    - Central Nervous System Agents: 56
      - Analgesics: 41572
        Calcitonin Gene-Related Peptide Receptor Antagonists: 508
  - Molecular Mechanisms of Pharmacological Action: 26
    - Calcitonin Gene-Related Peptide Receptor Antagonists: 508
  - Physiological Effects of Drugs: 1
    - Peripheral Nervous System Agents: 5
      - Sensory System Agents
        Analgesics: 41572
        Calcitonin Gene-Related Peptide Receptor Antagonists: 508

Abigail Pérez-Rodríguez Selected Research

Abigail Pérez-Rodríguez Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure